Epidemiology, Risk Factors, and Prevention of Pancreatic Cancer

  • Federico Mocchegiani
  • Roberto Ghiselli
  • Michela Cappelletti
  • Vittorio Saba
Part of the Updates in Surgery book series (UPDATESSURG)


Cancer of the pancreas is a neoplasm which occurs infrequently, although cases are increasing and the death rate is very high death. The incidence of this neoplasm in the United States is around 11 cases per 100,000 inhabitants, equating to around 30,000 new cases per year [1, 2]. In Europe, the incidence is around 5.2–8.7 cases per 100,000 inhabitants, with a lot of variations among the different nations [3, 4]. The lowest incidences have been recorded in Africa and in Asia, at 2 cases per 100,000 inhabitants, although over the last 40 years a large increase in the number of cases in Japan has been noticed, with 19,700 new cases per year (15 per 100,000 inhabitants) [2, 5] (Table 13.1). The growing trend appears to be mainly related to two factors: the rise in average age, which is the main risk factor for all the principal gastroenteric neoplasms, and the spread of tobacco-smoking habits.


Pancreatic Cancer Chronic Pancreatitis Familial Adenomatous Polyposis Pancreatic Carcinoma Pancreatic Neoplasm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ries LAG, Melbert D, Krapcho M et al (eds) (2008) SEER Cancer Statistics Review, 1975–2005, National Cancer Institute. Bethesda, MD., based on November 2007 SEER data submission, posted to the SEER web site, 2008Google Scholar
  2. 2.
    Japan National Cancer Center (2007) Cancer Statistic in Japan 2007. Scholar
  3. 3.
    Moossa AR (1991) Tumours of the pancreas. In: Moossa AR, Schimpf SC, Rabson MC (eds) Comprehensive textbook of oncology, vol 1, 2nd edn. Williams and Wilkins, Baltimore, pp 958–988Google Scholar
  4. 4.
    Mori K, Ikei S, Yamane T et al (1990) Pathological factors influencing survival of carcinoma of the ampulla of Vater. Eur J Surg Oncol 16(3):183–188PubMedGoogle Scholar
  5. 5.
    Lin Y, Tamakoshi A, Wakai K et al (1998) Descriptive epidemiology of pancreatic cancer in Japan. J Epidemiol 8(1):52–59PubMedGoogle Scholar
  6. 6.
    Parkin DM, Muir C, Whelan SL et al (1992) Cancer incidence in five continents. IARC Scientific Publications, Lyon 120:1–1033Google Scholar
  7. 7.
    Fraumeni JF Jr (1975) Cancers of the pancreas and biliary tract: epidemiological considerations. Cancer Res 35(11 Pt 2):3437–3446PubMedGoogle Scholar
  8. 8.
    Phillips AR, Lawes CM, Cooper GJ, Windsor JA (2002) Ethnic disparity of pancreatic cancer in New Zealand. Int J Gastrointest Cancer 31(1–3):137–145CrossRefPubMedGoogle Scholar
  9. 9.
    McCredie M, Cox B, Stewart JH (2000) Smoking-related cancers in Maori and non-Maori in New Zealand, 1974–1993: fewer bladder cancers among Maori. Asian Pac J Cancer Prev 1(3):221–225PubMedGoogle Scholar
  10. 10.
    Gold EB, Goldin SB (1998) Epidemiology of and risk factors for pancreatic cancer [review]. Surg Oncol Clin N Am 7(1):67–91PubMedGoogle Scholar
  11. 11.
    Pernick NL, Sarkar FH, Philip PA et al (2003) Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and Caucasians. Pancreas 26:28–32CrossRefPubMedGoogle Scholar
  12. 12.
    Parkin DM, Bray F, Ferlay F, Pisani P (2005) Global cancer statistics. CA Cancer J Clin 55(2):74–108CrossRefPubMedGoogle Scholar
  13. 13.
    Pisani P, Parkin DM, Bray F, Ferlay J (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83(1):18–29. Erratum in: Int J Cancer 83(6):870–873CrossRefPubMedGoogle Scholar
  14. 14.
    Phoa SS, Tilleman EH, van Delden OM et al (2005) Value of CT criteria in predicting survival in patients with potentially resectable pancreatic head carcinoma. J Surg Oncol 91(1):33–40CrossRefPubMedGoogle Scholar
  15. 15.
    Andren-Sandberg A, Neoptolemos JP (2002) Resection for pancreatic cancer in the new millennium. Pancreatology 2:431–439CrossRefPubMedGoogle Scholar
  16. 16.
    Bramhall SR, Allum WH, Jones AG et al (1995) Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease in the West Midlands: an epidemiological study. Br J Surg 82:111–115CrossRefPubMedGoogle Scholar
  17. 17.
    Shore S, Raraty M, Ghaneh P et al (2003) Chemotherapy for pancreatic cancer. Aliment Pharmacol Ther 18:1049–1069CrossRefPubMedGoogle Scholar
  18. 18.
    Neoptolemos JP, Dunn JA, Stocken DD et al (2001) Adjuvant chemoradiotherapy and chemotherapy in respectable pancreatic cancer: a randomized controlled trial. Lancet 358:1576–1585CrossRefPubMedGoogle Scholar
  19. 19.
    Yeo CJ, Cameron JL, Lillemoe KD et al (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 221(6):721–731CrossRefPubMedGoogle Scholar
  20. 20.
    Ariyama J, Suyama M, Satoh K, Wakabayashi K (1998) Endoscopic ultrasound and intraductal ultrasound in the diagnosis of small pancreatic tumors. Abdom Imaging 23(4):380–386CrossRefPubMedGoogle Scholar
  21. 21.
    Lochan R, Daly AK, Reeves HL, Charnley RM (2008) Genetic susceptibility in pancreatic ductal adenocarcinoma. Br J Surg 95(1):22–32CrossRefPubMedGoogle Scholar
  22. 22.
    Silverman DT, Dunn JA, Hoover RN et al (1994) Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst 86:1510–1516CrossRefPubMedGoogle Scholar
  23. 23.
    Mack TM, Yu MC, Hanisch R et al (1986) Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst 76:49–60PubMedGoogle Scholar
  24. 24.
    Lin Y, Tamakoshi A, Kawamura T et al (2002) A prospective cohort study of cigarette smoking and pancreatic cancer in Japan. Cancer Causes Control 13:249–254CrossRefPubMedGoogle Scholar
  25. 25.
    Akiba S, Hirayama T (1990) Cigarette smoking and cancer mortality risk in Japanese men and women — results from reanalysis of the six-prefecture cohort study data. Environ Health Perspect 87:19–26CrossRefPubMedGoogle Scholar
  26. 26.
    Fuchs CS, Colditz GA, Stampfer MJ et al (1996) A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med 156(19):2255–2260CrossRefPubMedGoogle Scholar
  27. 27.
    Doll R, Peto R, Wheatley K et al (1994) Mortality in relation to smoking: 40 years’ observations on male British doctors. Br Med J 309:901–911Google Scholar
  28. 28.
    Stolzenberg-Solomon RZ, Cross AJ, Silverman DT et al (2007) Meat and meat-mutagen intake and pancreatic cancer risk in the NIH-AARP cohort. Cancer Epidemiol Biomarkers Prev 16(12):2664–2675CrossRefPubMedGoogle Scholar
  29. 29.
    Baghurst PA, McMichael AJ, Slavotinek AH et al (1991) A case-control study of diet and cancer of the pancreas. Am J Epidemiol 134:167–179PubMedGoogle Scholar
  30. 30.
    Bueno de Mesquita HB, Maisonneuve P, Moerman CJ et al (1991) Intake of foods and nutrients and cancer of the exocrine pancreas: a population-based case-control study in the Netherlands. Int J Cancer 48:540–549CrossRefPubMedGoogle Scholar
  31. 31.
    Ghadirian P, Simard A, Baillargeon J et al (1991–1992) Nutritional factors and pancreatic cancer in the francophone community in Montreal, Canada. Int J Cancer 47:1–6; 52:17–23CrossRefPubMedGoogle Scholar
  32. 32.
    Ghadirian P, Thouez JP, PetitClerc C (1991) International comparisons of nutrition and mortality from pancreatic cancer. Cancer Detect Prev 15:357–362PubMedGoogle Scholar
  33. 33.
    Zatonski W, Przewozniak K, Howe GR et al (1991) Nutritional factors and pancreatic cancer: a case-control study from south-west Poland. Int J Cancer 48:390–394CrossRefPubMedGoogle Scholar
  34. 34.
    Howe GR, Ghadirian P, Bueno de Mesquita HB et al (1992) A collaborative case-control study of nutrient intake and pancreatic cancer within the SEARCH programme. Int J Cancer 51:365–372CrossRefPubMedGoogle Scholar
  35. 35.
    Stolzenberg-Solomon RZ, Pietinen P, Taylor PR et al (2002) Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol 155:783–792CrossRefPubMedGoogle Scholar
  36. 36.
    Ohba S, Nishi M, Miyake H (1996) Eating habits and pancreas cancer. Int J Pancreatol 20:37–42PubMedGoogle Scholar
  37. 37.
    Ojajarvi A, Partanen T, Ahlbom A et al (2001) Risk of pancreatic cancer in workers exposed to chlorinated hydrocarbon solvents and related compounds: a meta-analysis. Am J Epidemiol 153:841–850CrossRefPubMedGoogle Scholar
  38. 38.
    Collins JJ, Esmen NA, Hall TA (2001) A review and meta-analysis of formaldehyde exposure and pancreatic cancer. Am J Ind Med 39:336–345CrossRefPubMedGoogle Scholar
  39. 39.
    McCallion K, Mitchell RM, Wilson RH, Kee F et al (2001) Flexible sigmoidoscopy and the changing distribution of colorectal cancer: implications for screening. Gut 48:522–525CrossRefPubMedGoogle Scholar
  40. 40.
    Kauppinen T, Partanen T, Degerth R et al (1995) Pancreatic cancer and occupational exposures. Epidemiology 6:498–502CrossRefPubMedGoogle Scholar
  41. 41.
    Alguacil J, Kauppinen T, Porta M et al (2000) Risk of pancreatic cancer and occupational exposures in Spain. PANKRAS II Study Group. Ann Occup Hyg 44:391–403PubMedGoogle Scholar
  42. 42.
    Hoppin JA, Tolbert PE, Holly EA et al (2000) Pancreatic cancer and serum organochlorine levels. Cancer Epidemiol Biomarkers Prev 9:199–205PubMedGoogle Scholar
  43. 43.
    Porta M, Malats N, Jariod M et al (1999) Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group. Lancet 354:2125–2129CrossRefPubMedGoogle Scholar
  44. 44.
    Fryzek JP, Garabrant DH, Harlow SD et al (1997) A case-control study of self-reported exposures to pesticides and pancreas cancer in southeastern Michigan. Int J Cancer 72:62–67CrossRefPubMedGoogle Scholar
  45. 45.
    Michaud DS, Giovannucci E, Willett WC et al (2001) Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 286(8):921–929CrossRefPubMedGoogle Scholar
  46. 46.
    Ye W, Lagergren J, Weiderpass E et al (2002) Alcohol abuse and the risk of pancreatic cancer. Gut 51:236–239CrossRefPubMedGoogle Scholar
  47. 47.
    Partanen T, Hemminki K, Vainio H, Kauppinen T (1995) Coffee consumption not associated with risk of pancreas cancer in Finland. Prev Med 24(2):213–216CrossRefPubMedGoogle Scholar
  48. 48.
    Stensvold I, Jacobsen BK (1994) Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 5(5):401–408CrossRefPubMedGoogle Scholar
  49. 49.
    Michaud DS, Giovannucci E, Willett WC et al (2001) Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomarkers Prev 10(5):429–437PubMedGoogle Scholar
  50. 50.
    Brand RE, Lynch HT (2006) Genotype/phenotype of familial pancreatic cancer [review]. Endocrinol Metab Clin North Am 35(2):405–415, xiCrossRefPubMedGoogle Scholar
  51. 51.
    Lal G, Liu G, Schmocker B et al (2000) Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res 60:409–416PubMedGoogle Scholar
  52. 52.
    Kern SE, Hruban RH, Hidalgo M et al (2002) An introduction to pancreatic adenocarcinoma genetics, pathology and therapy. Cancer Biol Ther 1:607–613PubMedGoogle Scholar
  53. 53.
    Rulyak SJ, Lowenfels AB, Maisonneuve P et al (2003) Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology 124:1292–1299CrossRefPubMedGoogle Scholar
  54. 54.
    Maisonneuve P, FitzSimmons SC, Neglia JP et al (2003) Cancer risk in nontransplanted and transplanted cystic fibrosis patients: a 10-year study. J Natl Cancer Inst 95:381–387PubMedGoogle Scholar
  55. 55.
    Neglia JP, FitzSimmons SC, Maisonneuve P et al (1995) The risk of cancer among patients with cystic fibrosis. N Engl J Med 332:494–499CrossRefPubMedGoogle Scholar
  56. 56.
    Su GH, Hruban RH, Bansal RK et al (1999) Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol 154:1835–1840PubMedGoogle Scholar
  57. 57.
    Efthimiou E, Crnogorac-Jurcevic T, Lemoine NR (2001) Inherited predisposition to pancreatic cancer. Gut 48:143–147CrossRefPubMedGoogle Scholar
  58. 58.
    Goldstein AM, Fraser MC, Streuwing JP et al (1995) Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med 333:970–974CrossRefPubMedGoogle Scholar
  59. 59.
    Hahn SA, Bartsch DK (2005) Genetics of hereditary pancreatic carcinoma. Clin Lab Med 25(1):117–133CrossRefPubMedGoogle Scholar
  60. 60.
    Greer JB, Whitcomb DC, Brand RE (2007) Genetic predisposition to pancreatic cancer: a brief review. Am J Gastroenterol 102(11):2564–2569CrossRefPubMedGoogle Scholar
  61. 61.
    Harris CC (1989) Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair. Carcinogenesis 10(9):1563–1566CrossRefPubMedGoogle Scholar
  62. 62.
    Foster JR, Idle JR, Hardwick JP et al (1993) Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis. J Pathol 169:457–463CrossRefPubMedGoogle Scholar
  63. 63.
    Duell EJ, Holly EA, Bracci PM et al (2002) A population-based case-control study of polymorphisms in carcinogen-metabolizing genes, smoking and pancreatic adenocarcinoma risk. J Natl Cancer Inst 94:297–306PubMedGoogle Scholar
  64. 64.
    Bartsch H, Malaveille C, Lowenfels AB et al (1998) Genetic polymorphism of N-acetyltransferases, glutathione S transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk. The International Pancreatic Disease Study Group. Eur J Cancer Prev 7:215–223CrossRefPubMedGoogle Scholar
  65. 65.
    Ockenga J, Vogel A, Teich N et al (2003) UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology 124:1802–1808CrossRefPubMedGoogle Scholar
  66. 66.
    Lowenfels AB, Maisonneuve P, Cavallini G et al (1993) Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 328:1433–1437CrossRefPubMedGoogle Scholar
  67. 67.
    Lowenfels AB, Maisonneuve P, DiMagno EP et al (1997) Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 89:442–446CrossRefPubMedGoogle Scholar
  68. 68.
    Chari ST, Mohan V, Pitchumoni CS et al (1994) Risk of pancreatic carcinoma in tropical calcifying pancreatitis: an epidemiologic study. Pancreas 9:62–66CrossRefPubMedGoogle Scholar
  69. 69.
    Lowenfels AB, Maisonneuve P, Whitcomb DC et al (2001) Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 286(2):169–170CrossRefPubMedGoogle Scholar
  70. 70.
    Everhart J, Wright D (1995) Diabetes mellitus as a risk factor for pancreatic cancer. A metaanalysis. JAMA 273:1605–1609CrossRefPubMedGoogle Scholar
  71. 71.
    Chari ST, Leibson CL, Rabe KG et al (2005) Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 129(2):504–511PubMedGoogle Scholar
  72. 72.
    Huxley R, Ansary-Moghaddam A, Berrington de Gonz ález A et al (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92(11):2076–2083CrossRefPubMedGoogle Scholar
  73. 73.
    Karmody AJ, Kyle J (1969) The association between carcinoma of the pancreas and diabetes mellitus. Br J Surg 56:362–364CrossRefPubMedGoogle Scholar
  74. 74.
    Permert J, Adrian TE, Jacobsson P et al (1993) Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg 165:61–66CrossRefPubMedGoogle Scholar
  75. 75.
    Permert J, Ihse I, Jorfeldt L et al (1993) Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 159:101–107PubMedGoogle Scholar
  76. 76.
    Chu TM (1997) Molecular diagnosis of pancreas carcinoma. J Clin Lab Anal 11:225–231CrossRefPubMedGoogle Scholar
  77. 77.
    Vimalachandran D, Ghaneh P, Costello E, Neoptolemos JP (2004) Genetics and prevention of pancreatic cancer. Cancer Control 11(1):6–14PubMedGoogle Scholar
  78. 78.
    Norell SE, Ahlbom A, Erwald R et al (1986) Diet and pancreatic cancer: a case-control study. Am J Epidemiol 124:894–902PubMedGoogle Scholar
  79. 79.
    Kokawa A, Kondo H, Gotoda T et al (2001) Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors. Cancer 91:333–338CrossRefPubMedGoogle Scholar
  80. 80.
    Anderson KE, Johnson TW, Lazovich D et al (2002) Association between nonsteroidal antiinflammatory drug use and the incidence of pancreatic cancer. J Natl Cancer Inst 94:1168–1171PubMedGoogle Scholar
  81. 81.
    Larsson SC, Giovannucci E, Bergkvist L, Wolk A (2006) Aspirin and nonsteroidal antiinflammatory drug use and risk of pancreatic cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(12):2561–2564CrossRefPubMedGoogle Scholar
  82. 82.
    Doucas H, Garcea G, Neal CP et al (2006) Chemoprevention of pancreatic cancer: a review of the molecular pathways involved, and evidence for the potential for chemoprevention [review]. Pancreatology 6(5):429–439CrossRefPubMedGoogle Scholar
  83. 83.
    Holly EA, Chaliha I, Bracci PM, Gautam M (2004) Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area. Clin Gastroenterol Hepatol 2(6):510–517CrossRefPubMedGoogle Scholar
  84. 84.
    Niederau C, Grendell JH (1992) Diagnosis of pancreatic carcinoma. Imaging techniques and tumor markers. Pancreas 7(1):66–86PubMedCrossRefGoogle Scholar
  85. 85.
    Steinberg W (1990) The clinical utility of the CA 19-9 tumor-associated antigen [review]. Am J Gastroenterol 85(4):350–355PubMedGoogle Scholar
  86. 86.
    Saisho H, Yamaguchi T (2004) Diagnostic imaging for pancreatic cancer: computed tomography, magnetic resonance imaging, and positron emission tomography. Pancreas 28(3):273–278CrossRefPubMedGoogle Scholar
  87. 87.
    Yasuda K, Mukai H, Nakajima M (1995) Endoscopic ultrasonography diagnosis of pancreatic cancer. Gastrointest Endosc Clin North Am 5(4):699–712Google Scholar
  88. 88.
    Durie P, Lerch MM, Lowenfels AB et al (2002) Genetic disorders of the exocrine pancreas. An overview and update. Karger, BaselGoogle Scholar
  89. 89.
    McFaul CD, Greenhalf W, Earl J et al (2006) Anticipation in familial pancreatic cancer. Gut 55:252–258CrossRefPubMedGoogle Scholar
  90. 90.
    Brentnall TA, Bronner MP, Byrd DR et al (1999) Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 131:247–255PubMedGoogle Scholar
  91. 91.
    Brentnall TA (2000) Cancer surveillance of patients from familial pancreatic cancer kindreds. Med Clin North Am 84:707–718CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • Federico Mocchegiani
    • 1
  • Roberto Ghiselli
    • 1
  • Michela Cappelletti
    • 1
  • Vittorio Saba
    • 1
  1. 1.Division of Surgery, U. Sestilli HospitalPolytechnic University of MarcheAnconaItaly

Personalised recommendations